| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-108 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8128 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
1987-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5112a0b05b8e784f2c4dfb590c25c4fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c06267ebb5e0ea10381791abee28926d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f597c0327823b0d4297758b521f763f |
| publicationDate |
1992-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1305932-C |
| titleOfInvention |
Process for the preparation of human antithrombin iii (atiii), vectors and host cells suitable for this purpose, biologically active atiii obtained in this way and medicaments containing the latter |
| abstract |
ABSTRACT OF THE DISCLOSURE Human antithrombin III (ATIII) which has progressive in-hibitor activity and is stimulated by heparin is advant-geously obtained by expression after cotransfection of mammalian cells whose dihydrofolate reductase (DHFR) ac-tivity is deficient (dhfr-) with a) vectors which contain the ATIII cDNA, and b) vectors which carry the DHFR gene, in particular after gene amplification using methotrexate. |
| priorityDate |
1986-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |